---
type: "Symbol"
title: "Adlai Nortye (ANL.US) — 社區討論"
description: "該股票的社區討論，包括分析師觀點、財報解讀和投資策略，來自認證金融專業人士和活躍投資者。"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ANL.US/topics.md"
symbol: "ANL.US"
parent: "https://longbridge.com/zh-HK/quote/ANL.US.md"
count: 2
datetime: "2026-03-17T13:30:24.631Z"
locales:
  - [en](https://longbridge.com/en/quote/ANL.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ANL.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ANL.US/topics.md)
---

# Adlai Nortye (ANL.US) — 社區討論

### [Today was really a day of watching the market in d…](https://longbridge.com/zh-HK/topics/37445183.md)

- 作者: [土肥圆](https://longbridge.com/zh-HK/profiles/15025829.md)
- 日期時間: 2025-12-30T10:42:27.000Z
- 評論: 2
- Today was really a day of watching the market in despair... $USA Rare Earth(USAR.US) and $Sunnova Energy(NOVA.US) plummeted again, and cyclical stocks like rare earth and gold mines got schooled witho

**評論:**

- **养乐多o.o · 2025-12-31T15:11:48.000Z**: Can US stocks still recover?
- **ST欧阳昆汀 · 2025-12-30T16:35:27.000Z**: The call I bought for 260320 has a 99.99% chance of being recognized as a loss

### [Profile 中的明珠，拥有全球临床研发能力的阿诺医药 “扬帆” 纳斯达克](https://longbridge.com/zh-HK/topics/10051051.md)

- 作者: [明大教主](https://longbridge.com/zh-HK/profiles/6871671.md)
- 日期時間: 2023-09-29T12:47:47.000Z
- 評論: 0
- 序：医药作为非周期的永续行业，长期受到国内外投资者的关注。但 2018 年集采后，我国医药板块走势出现分化，A 股医药连续 5 年估值在低位徘徊。在国内集采 + 国谈的大背景下，已有少数 Profile 先驱企业尝试全球化商业路线，其中今天在纳斯达克上市的$Adlai Nortye(ANL.US) 就是其中之一！集采背景下...

## 參考連結

- [Adlai Nortye (ANL.US)](https://longbridge.com/zh-HK/quote/ANL.US.md)


> 支持的語言: [English](https://longbridge.com/en/quote/ANL.US/topics.md) | [简体中文](https://longbridge.com/zh-CN/quote/ANL.US/topics.md)